Biotronik Catheter Gets FDA Approval | DAIC
Biotronik's Selectra 3D catheter and Solia S lead receive FDA approval for left bundle branch area pacing (LBBAP), used in over 80,000 patients globally. BIO-CONDUCT trial results show high implant success (95.7%) and low complications (1.7%) at 3 months.
Reference News
Biotronik Catheter Gets FDA Approval | DAIC
Biotronik's Selectra 3D catheter and Solia S lead receive FDA approval for left bundle branch area pacing (LBBAP), used in over 80,000 patients globally. BIO-CONDUCT trial results show high implant success (95.7%) and low complications (1.7%) at 3 months.